Serum Levels of Calcitonin Gene-related Peptide and Substance P are Decreased in Patients with Diabetes Mellitus and Coronary Artery Disease

Author： Wang LH Zhou SX Li RC Zheng LR Zhu JH Hu SJ Sun YL

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.1, 2012-01, pp. : 134-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Pilocarpine on Levels of Substance P and α-Calcitonin Gene-related Peptide in Human Saliva

By Nagano T. Itoh H. Hayashi T. Takeyama M.

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 9, 1999-09 ,pp. : 571-574

Pharmaceutical Press

Access to resources Recommend Favorite

Inhibitory effects of calcitonin gene-related peptide on substance-P-induced superoxide production in human neutrophils

By Tanabe T. Otani H. Zeng X.-T. Mishima K. Ogawa R. Inagaki C.

European Journal of Pharmacology, Vol. 321, Iss. 1, 1997-02 ,pp. : 137-141

Elsevier

Access to resources Recommend Favorite

Inhibitory effects of calcitonin gene-related peptide on substance-P-induced superoxide production in human neutrophils

By Tanabe T. Otani H. Xun-Ting Z. Mishima K. Ogawa R. Inagaki C.

European Journal of Pharmacology, Vol. 314, Iss. 1, 1996-10 ,pp. : 175-183

Elsevier

Access to resources Recommend Favorite

Immunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders

By Dömötör András

Inflammopharmacology, Vol. 13, Iss. 1-3, 2005-08 ,pp. : 161-177

VSP

Access to resources Recommend Favorite

Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease

Current Pharmaceutical Design, Vol. 18, Iss. 33, 2012-11 ,pp. : 5273-5293

Bentham Science Publishers

Access to resources Recommend Favorite